Monday, September 22, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

David Scharfs Positive Outlook on OneMain Holdings and Increased Price Target

Elaine Mendonca by Elaine Mendonca
January 12, 2024
in Breaking News
0
Finance_ Chart Down
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

On January 12, 2024, David Scharf, an esteemed Wall Street analyst at JMP Securities, expressed his positive outlook on OneMain Holdings (NYSE: OMF). Scharf maintains a Market Outperform rating on the stock and has increased the price target from $46 to $53. This aligns with the average one-year price target for OneMain Holdings, which stands at $52.96. Notably, analysts’ forecasts for the stock range from a low of $41.41 to a high of $65.10.

With a keen focus on the financial sector, Scharf covers a total of 33 stocks. His success rate of 54.42% further solidifies his reputation as a knowledgeable and reliable analyst in the industry.

OMF Stock Price Declines Slightly on January 12, 2024: Factors to Consider for Investment Decisions

On January 12, 2024, OneMain Holdings Inc. (OMF) experienced a slight decline in its stock price. The price of OMF shares decreased by $0.11 since the market last closed, representing a drop of 0.22%. The closing price on the previous day was $49.75. Additionally, the stock experienced a drop of $0.15 in pre-market trading. It is important for investors to consider various factors, such as market trends, investor sentiment, and company-specific news, before making any investment decisions. While OMF has been trading near the top of its 52-week range and above its 200-day simple moving average, the decline in price on January 12 should be closely monitored to determine its significance. Conducting a thorough analysis of OMF’s financials, market conditions, and recent news or events is advisable, and consulting with a financial advisor or professional can provide valuable insights and guidance.

OneMain Holdings Inc. (OMF): Mixed Performance in Stock Market Operations with Impressive Q4 Rebound

On January 12, 2024, OneMain Holdings Inc. (OMF) displayed mixed performance in its stock market operations. The company’s financials, as reported by CNN Money, showed that while the total revenue remained flat since the previous year, it witnessed a modest increase of 3.84% in the last quarter. Similarly, the net income experienced a significant decline of 33.18% over the year, but rebounded impressively with an 88.35% increase in the last quarter. The earnings per share (EPS) also saw a decline of 28.54% over the year, followed by a remarkable increase of 88.19% in the last quarter.

Tags: OMF
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
MMM stock news

Analyst Downgrades 89bio Rating and Sets 15 Price Target

Finance_Accounting

JMP Securities Analyst Raises Price Target for Open Lending Maintains Market Outperform Rating

Finance_Capitalistic

JMP Securities Analyst Maintains Positive Outlook on LegalZoomcom with Slight Price Target Adjustment

Recommended

C3.ai Stock

C3.ai Shares Plunge Amid Mounting Challenges

2 weeks ago
Deutsche Bank Stock

Deutsche Bank Faces Critical Weekend with Dual Operational and Market Challenges

1 month ago
Airbnb Stock

Insider Selling and Institutional Uncertainty Cloud Airbnb’s Outlook

1 month ago
BioNTech Stock

Why BioNTech’s Strong Clinical Data Fails to Impress the Market

1 week ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Strong Earnings and Mixed Signals: Horace Mann Educators’ Q2 Performance

QuantumScape Shares Defy Insider Selling With Major Weekly Rally

Lockheed Martin’s Vectis: A New Era in Unmanned Aerial Combat

Dynex Capital’s Dividend Sustainability Questioned Amid Massive Payout Ratio

Pfizer’s Strategic Gambit: A $7.3 Billion Entry into the Weight-Loss Arena

Nike Shares Face Critical Earnings Test

Trending

Maravai LifeSciences Holdings Registered (A) Stock
Analysis

Is There Any Hope Left for Maravai LifeSciences Investors?

by Dieter Jaworski
September 22, 2025
0

Maravai LifeSciences Holdings Registered (A) shares continue their relentless downward trajectory, leaving shareholders to question whether a...

G III Apparel Stock

G-III Apparel Shares Face Significant Headwinds Following Disappointing Earnings

September 22, 2025
Infinera Stock

Nokia Finalizes Landmark $2.3 Billion Acquisition of Infinera

September 22, 2025
Horace Mann Educators Stock

Strong Earnings and Mixed Signals: Horace Mann Educators’ Q2 Performance

September 22, 2025
QuantumScape Stock

QuantumScape Shares Defy Insider Selling With Major Weekly Rally

September 22, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Is There Any Hope Left for Maravai LifeSciences Investors?
  • G-III Apparel Shares Face Significant Headwinds Following Disappointing Earnings
  • Nokia Finalizes Landmark $2.3 Billion Acquisition of Infinera

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com